Hunterbrook Media

BREAKING: Microsoft Denies Partnership with Richtech Robotics Beep, boop, fraud?

Who knows what Richtech learned about software engineering at the Microsoft Innovation Lab program? But what’s clear is they could teach a course of their own on financial engineering. Read our first piece on $RR at hntrbrk.com/richtech.

This comes months after short seller Capybara Research published a report on September 30, 2025 calling Richtech a "China Hustle" that is "riddled with fraud" and "uninvestable."

Their wild allegations:
x.com/CapybaraShor...

allowing institutional investors to buy stock at a cheaper price than retail. (2/2)

The playbook, in other words, seems to be: Miss your 10-K deadline, limiting your ability to fundraise; announce a collaboration that Microsoft says has "no commercial element;" watch the stock surge 44%; then disclose a private placement the next morning, (1/2)

That means the institution in the private placement may have gotten shares much cheaper than the retail traders bidding it up.

The phrase “under Nasdaq rules” is doing the heavy lifting there. Under those guidelines, "at the market" means at or above the lower of the prior close or trailing 5-day average, which in this case would include the four days before the 40%+ pump.

The morning after the 40% pop, Richtech announced a $38.7 million private placement. Unlike ATM offerings, private placements under Reg D don't require S-3 eligibility. The company called it "priced at-the-market under Nasdaq rules."

For a company burning $20 million/year on $5 million in revenue, losing access to capital markets could be an existential problem. So Richtech needed another way to raise money. Enter: the Microsoft "collaboration."

Missing the deadline may have serious fundraising consequences. To use Form S-3 — which enables shelf offerings and ATM programs — companies need 12 months of timely filings. Richtech's $1 billion shelf registration filed in September may now be frozen until January 2027.

Richtech’s press release came after the company missed its extended 10-K deadline on January 13. Richtech finally filed on January 20 — a week late. No 8-K was filed disclosing a Nasdaq deficiency notice, raising questions about whether one was received and not disclosed.

What’s the reason for the timing of this apparent pump?

We have one idea:

That's … not exactly how Richtech framed it. CEO Wayne Huang touted a "close collaboration" in which "our teams were able to jointly develop and deploy intelligent capabilities." The stock surged more than 40% in a single day.

You can apply here! The application is very quick! aiotlabs.microsoft.com/en

What are the AI Co-Innovation Labs? Microsoft's website describes the program as offering "one-week long complimentary, personalized development sprints" available to "any customers/partners looking to implement Microsoft's AI tools" — including "startups."

"There is no commercial element in this lab engagement." (2/2)

"Richtech participated in an AI Co-Innovation Lab engagement, which is a standard customer engagement focused on exploring and prototyping AI solutions using Microsoft technologies," a Microsoft partnerships representative told Hunterbrook Media. (1/2)

Based on Hunterbrook Media’s reporting, Hunterbrook Capital is short $RR and long a basket of comparable securities at the time of publication. Positions may change at any time. See full disclosures on our website.

BREAKING: Microsoft denies "commercial" relationship with Richtech Robotics — after $RR added $370 million in market cap after announcing a "close collaboration." Microsoft told us the engagement was a "standard" customer program.

Ubiquiti: The U.S. Tech Enabling Russia's Drone War Based on Hunterbrook Media’s reporting, Hunterbrook Capital is short $UI and long a basket of comparable securities at the time of publication. Positions may change at any time. See full disclosures b...

Read the full investigation and see full disclosures at hntrbrk.com/ubiquiti/

Hunterbrook’s months-long investigation found Ubiquiti wireless bridges — banned from export to Russia under U.S. and EU laws — are widely used by Russian troops, including possibly in drone operations against Ukrainian civilians that the U.N. has called crimes against humanity.

YouTube video by Hunterbrook Grizzly Affair: How an NBA Owner's Company Powers Russian Battlefield Communications in Ukraine

BREAKING: Grizzly Affair — American tech company’s networking gear is powering Russian battlefield communications in Ukraine. The company is Ubiquiti, $UI, a $34 billion Wi-Fi giant whose founder became the youngest owner of an NBA Team in 2012.

youtu.be/Fp5m0AzwsPk

“Bullshit” — The New Way Health Giants Hide Billions Three mysterious entities. Tens of billions in revenue. CVS, UnitedHealth, and Cigna created "PBM GPO" subsidiaries to divert billions of dollars.

Insurance giants are hiding billions meant to lower Americans’ drug costs.

Our year-long investigation details how CVS, UnitedHealth, and Cigna created shell companies to evade reform efforts and hide payments received from drugmakers.

Read our full investigation: hntrbrk.com/pbmgpo/

On paper, 3 little-known companies seem to generate more revenue per employee than $AAPL or $NVDA. Many times over.

Who are they? Are these really the most lucrative businesses in history?

... Or a front?

Tomorrow, Hunterbrook drops a massive exposé.

Sign up: newsletter@hntrbrk.com

“Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers Achieve Life Sciences ($ACHV) is near FDA approval of cytisinicline as a safe, effective treatment for smoking addiction.

A rare feel-good story from @truth the holidays! hntrbrk.com/achieve/

"There is a big demand for vaping cessation. People who are smoking cigarettes and who may be dual using by also vaping, are also interested in vaping cessation."

"An analysis from the Massachusetts General Hospital suggested that if cytisinicline became immediately available, approximately 71,000 people could quit smoking in one year and maintain long-term abstinence," said Dr. Maya Vijayaraghavan, a professor of medicine at UCSF.

"2 in 3 adults who smoke want to quit and yet more than 9 in 10 quit attempts fail. Adults who use tobacco and want to quit need access to evidence-based quit aids."

"There are 28.8 million adults in the US who smoke cigarettes and 11 million adults who vape nicotine," said Dr. Prochaska — a Stanford professor of medicine, a consultant to Achieve, and a director of Stanford Health Care's tobacco treatment service.

"Cytisinicline has been used safely for decades by many millions of people in Europe and has clear efficacy," said Dr. Robert West, a smoking cessation expert at University College London.

He says the FDA "definitely should" approve the option for Americans.

"It treats the addiction, that's amazing," said Dr. Mary O'Sullivan, founder and director of the smoking cessation clinic at Mount Sinai Health System. "Put it in the water!"